病毒耐药性：机制与后果 - Suppr

Suppr

超能文献

Virus drug-resistance: mechanisms and consequences.

作者信息

Larder B A, Darby G

出版信息

Antiviral Res. 1984 Apr;4(1-2):1-42. doi: 10.1016/0166-3542(84)90023-8.

DOI:10.1016/0166-3542(84)90023-8

PMID:6331303

Abstract

摘要

相似文献

Virus drug-resistance: mechanisms and consequences.

Antiviral Res. 1984 Apr;4(1-2):1-42. doi: 10.1016/0166-3542(84)90023-8.

Genetic mechanisms of resistance to acyclovir in herpes simplex virus.

Am J Med. 1982 Jul 20;73(1A):361-8. doi: 10.1016/0002-9343(82)90123-1.

Prophylaxis: a strategy to minimise antiviral resistance.

Lancet. 1984 May 26;1(8387):1154-5. doi: 10.1016/s0140-6736(84)91396-5.

Aphidicolin resistance in herpes simplex virus type 1 appears to alter substrate specificity in the DNA polymerase.

J Virol. 1989 Jun;63(6):2874-6. doi: 10.1128/JVI.63.6.2874-2876.1989.

Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1.

Am J Med. 1982 Jul 20;73(1A):351-60. doi: 10.1016/0002-9343(82)90122-x.

Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.

Am J Med. 1982 Jul 20;73(1A):387-92. doi: 10.1016/0002-9343(82)90129-2.

Cellular and herpesvirus polymerases: their significance for chemotherapy.

Adv Ophthalmol. 1979;38:187-96.

Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci.

Proc Natl Acad Sci U S A. 1980 Apr;77(4):2270-3. doi: 10.1073/pnas.77.4.2270.

Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.

J Infect Dis. 1999 Aug;180(2):487-90. doi: 10.1086/314900.

Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.

Virology. 1989 Feb;168(2):221-31. doi: 10.1016/0042-6822(89)90261-4.

引用本文的文献

Combination of ganciclovir and trifluridine prevents drug-resistance emergence in HSV-1.

Antimicrob Agents Chemother. 2024 May 2;68(5):e0011024. doi: 10.1128/aac.00110-24. Epub 2024 Apr 15.

Penciclovir susceptibilities of herpes simplex virus isolates from patients using penciclovir cream for treatment of recurrent herpes labialis.

Antimicrob Agents Chemother. 2002 Sep;46(9):2848-53. doi: 10.1128/AAC.46.9.2848-2853.2002.

Efficacies of gel formulations containing foscarnet, alone or combined with sodium lauryl sulfate, against establishment and reactivation of latent herpes simplex virus type 1.

Antimicrob Agents Chemother. 2001 Apr;45(4):1030-6. doi: 10.1128/AAC.45.4.1030-1036.2001.

Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues.

J Virol. 2001 Apr;75(7):3105-10. doi: 10.1128/JVI.75.7.3105-3110.2001.

Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.

J Virol. 2001 Feb;75(4):1761-9. doi: 10.1128/JVI.75.4.1761-1769.2001.

Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.

Drugs. 2000 Apr;59(4):839-63. doi: 10.2165/00003495-200059040-00013.

Survey of resistance of herpes simplex virus to acyclovir in northwest England.

Antimicrob Agents Chemother. 1998 Apr;42(4):868-72. doi: 10.1128/AAC.42.4.868.

What clinicians need to know about antiviral drugs and viral resistance.

Infect Dis Clin North Am. 1997 Dec;11(4):945-67. doi: 10.1016/s0891-5520(05)70399-8.

Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.

Drugs. 1996 Nov;52(5):754-72. doi: 10.2165/00003495-199652050-00009.

Molecular analysis of a neurovirulent herpes simplex virus type 2 strain with reduced thymidine kinase activity.

Arch Virol. 1993;131(1-2):61-73. doi: 10.1007/BF01379080.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验